Characteristics NLD group (N = 17) LD group (N = 20) P value
Male/female, n (%) 13/4 (76/24) 16/4 (80/20) 0.617
Age (year), median (IQR) 52 (50.5-62) 59 (49.8-69) 0.414
Days from onset of symptoms-to-hospitalization, median (IQR) 7 (4.5-7.5) 6.5 (5-7) 0.185
Fever (°F), median (IQR) 101 (100-101.5) 100.5 (100-101.75) 0.912
Dry cough, n (%) 17 (100) 20 (100) 0.001
Shortness of breath, n (%) 14 (82.4) 16 (80) 0.855
Weakness, n (%) 17 (100) 20 (100) 0.001
Diarrhea, n (%) 3 (17.6) 5 (25) 0.289
Anosmia, n (%) 11 (64.7) 14 (70) 0.516
Sore throat, n (%) 9 (52.9) 12 (60) 0.043
Diabetes, n (%) 14 (82.4) 17 (85) 0.675
Hypertension, n (%) 13 (76.5) 12 (60) 0.043
CVD, n (%) 6 (35.3) 4 (20) 0.052
Bronchial asthma, n (%) 4 (23.5) 6 (30) 0.389
CKD, n (%) 2 (11.8) 3 (15) 0.577
COPD, n (%) 2 (11.8) 3 (15) 0.577
Severe obesity, n (%) 2 (11.8) 2 (10) 0.740
Malignancy, n (%) 1 (5.9) 3 (15) 0.075
PD, n (%) 0 (0) 2 (10) 0.005
SpO2 (%), median (IQR) 89 (87.5-90) 89.5 (88-90) 0.718
Respiratory rate, (breaths/min), median (IQR) 22 (20.5-24) 23 (21-24) 0.825
PaO2/FiO2 (mmHg), median (IQR) 240 (195.5-263.5) 245 (193.8-262.3) 0.010
Heart rate (beat/min), median (IQR) 98 (85.5-105.5) 94.5 (84.5-113) 0.174
CRP (mg/L), median (IQR) 43.5 (30-220) 77.1 (40.9-211.5) 0.946
Procalcitonin (ng/mL), median (IQR) 0.12 (0.06-0.49) 0.18 (0.07-0.86) 0.062
WBC (K/µL), median (IQR) 6.3 (4.7-10) 8 (6.3-14.3) 0.021
Neutrophils (%), median (IQR) 87.6 (79.4-92.1) 82.5 (76.8-88.1) 0.657
Lymphocytes (%), median (IQR) 13.9 (11.9-15.8) 12.2 (8.2-14.5) 0.006
Platelet (K/µL), median (IQR) 186 (128-255) 175 (133.3-245.3) 0.605
D-Dimer (mg /L FEU), median (IQR) 2.7 (1.7-7.6) 2 (1.5-3.2) 0.018
Serum Ferritin (ng/mL), median (IQR) 434 (293.5-543.5) 470 (361.3-604.8) 0.227
LDH ((U/L), median (IQR) 272 (216-404.5) 334 (295-390.5) 0.009
Creatinine (mg/dL), median (IQR) 0.9 (0.8-1) 0.9 (0.7-1.1) 0.210
ALT (U/L), median (IQR) 34 (29-57) 44 (35-54) 0.13
AST (U/L), median (IQR) 35 (25.5-49) 40 (29.5-58.8) 0.349
MEWS, median (IQR) 3 (2-3) 3 (2-3) 0.476